Frontrunner in Translation: Progressive Supranuclear Palsy
- PMID: 31695675
- PMCID: PMC6817677
- DOI: 10.3389/fneur.2019.01125
Frontrunner in Translation: Progressive Supranuclear Palsy
Abstract
Progressive supranuclear palsy (PSP) is a four-repeat tau proteinopathy. Abnormal tau deposition is not unique for PSP and is the basic pathologic finding in some other neurodegenerative disorders such as Alzheimer's disease (AD), age-related tauopathy, frontotemporal degeneration, corticobasal degeneration, and chronic traumatic encephalopathy. While AD research has mostly been focused on amyloid beta pathology until recently, PSP as a prototype of a primary tauopathy with high clinical-pathologic correlation and a rapid course is a crucial candidate for tau therapeutic research. Several novel approaches to slow disease progression are being developed. It is expected that the benefits of translational research in this disease will extend beyond the PSP population. This article reviews advances in the diagnosis, epidemiology, pathology, hypothesized etiopathogenesis, and biomarkers and disease-modifying therapeutic approaches of PSP that is leading it to become a frontrunner in translation.
Keywords: biomarker; epidemiology; etiopathogenesis; progressive supranuclear palsy; tauopathy; translational research.
Copyright © 2019 Shoeibi, Olfati and Litvan.
Figures
![Figure 1](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/6817677/bin/fneur-10-01125-g0001.gif)
![Figure 2](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/6817677/bin/fneur-10-01125-g0002.gif)
![Figure 3](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/6817677/bin/fneur-10-01125-g0003.gif)
![Figure 4](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/6817677/bin/fneur-10-01125-g0004.gif)
Similar articles
-
Motor neuron TDP-43 proteinopathy in progressive supranuclear palsy and corticobasal degeneration.Brain. 2022 Aug 27;145(8):2769-2784. doi: 10.1093/brain/awac091. Brain. 2022. PMID: 35274674
-
PET Tau Imaging and Motor Impairments Differ Between Corticobasal Syndrome and Progressive Supranuclear Palsy With and Without Alzheimer's Disease Biomarkers.Front Neurol. 2020 Jul 10;11:574. doi: 10.3389/fneur.2020.00574. eCollection 2020. Front Neurol. 2020. PMID: 32754109 Free PMC article.
-
Progressive supranuclear palsy.Int Rev Neurobiol. 2019;149:49-86. doi: 10.1016/bs.irn.2019.10.013. Epub 2019 Nov 21. Int Rev Neurobiol. 2019. PMID: 31779824 Review.
-
Divergent CSF τ alterations in two common tauopathies: Alzheimer's disease and progressive supranuclear palsy.J Neurol Neurosurg Psychiatry. 2015 Mar;86(3):244-50. doi: 10.1136/jnnp-2014-308004. Epub 2014 Jun 4. J Neurol Neurosurg Psychiatry. 2015. PMID: 24899730 Free PMC article.
-
Advances in progressive supranuclear palsy: new diagnostic criteria, biomarkers, and therapeutic approaches.Lancet Neurol. 2017 Jul;16(7):552-563. doi: 10.1016/S1474-4422(17)30157-6. Epub 2017 Jun 13. Lancet Neurol. 2017. PMID: 28653647 Free PMC article. Review.
Cited by
-
Hypometabolism, Alzheimer's Disease, and Possible Therapeutic Targets: An Overview.Cells. 2023 Aug 8;12(16):2019. doi: 10.3390/cells12162019. Cells. 2023. PMID: 37626828 Free PMC article. Review.
-
C-STIM: Protocol for a randomized, single-blind, crossover study of cerebellar repetitive transcranial magnetic stimulation (rTMS) for postural instability in people with progressive supranuclear palsy (PSP).Contemp Clin Trials Commun. 2023 Jul 14;35:101165. doi: 10.1016/j.conctc.2023.101165. eCollection 2023 Oct. Contemp Clin Trials Commun. 2023. PMID: 37538197 Free PMC article.
-
Pathomechanisms of depression in progressive supranuclear palsy.J Neural Transm (Vienna). 2023 Aug;130(8):1049-1056. doi: 10.1007/s00702-023-02621-w. Epub 2023 Mar 18. J Neural Transm (Vienna). 2023. PMID: 36933007 Review.
-
Pathomechanisms of cognitive impairment in progressive supranuclear palsy.J Neural Transm (Vienna). 2023 Apr;130(4):481-493. doi: 10.1007/s00702-023-02613-w. Epub 2023 Mar 2. J Neural Transm (Vienna). 2023. PMID: 36862189 Review.
-
Why Therapeutic Trials Fail in Primary Tauopathies.Mov Disord. 2023 Apr;38(4):545-550. doi: 10.1002/mds.29322. Epub 2023 Jan 20. Mov Disord. 2023. PMID: 36670054 Free PMC article. No abstract available.
References
-
- Lindwall G, Cole RD. Phosphorylation affects the ability of tau protein to promote microtubule assembly. J Biol Chem. (1984) 259:5301–5. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous